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a b s t r a c t
Cell fate speciﬁcation during organogenesis is usually followed by a phase of cell proliferation to produce
the required number of differentiated cells. The Caenorhabditis elegans vulva is an excellent model to
study how cell fate speciﬁcation and cell proliferation are coordinated. The six vulval precursor cells
(VPCs) are born at the ﬁrst larval stage, but they arrest in the G1 phase of the cell cycle until the be-
ginning of the third larval stage, when their fates are speciﬁed and the three proximal VPCs proliferate to
generate 22 vulval cells. An epidermal growth factor (EGF) signal from the gonadal anchor cell combined
with lateral DELTA/NOTCH signaling between the VPCs determine the primary (1°) and secondary (2°)
fates, respectively. The hox gene lin-39 plays a key role in integrating these spatial patterning signals and
in maintaining the VPCs as polarized epithelial cells. Using a fusion-defective eff-1(lf) mutation to keep
the VPCs polarized, we ﬁnd that VPCs lacking lin-39 can neither activate lateral NOTCH signaling nor
proliferate. LIN-39 promotes cell cycle progression through two distinct mechanisms. First, LIN-39
maintains the VPCs competent to proliferate by inducing cdk-4 cdk and cye-1 cyclinE expression via a
non-canonical HOX binding motif. Second, LIN-39 activates in the adjacent VPCs the NOTCH signaling
pathway, which promotes VPC proliferation independently of LIN-39. The hox gene lin-39 is therefore a
central node in a regulatory network coordinating VPC differentiation and proliferation.
& 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
During organogenesis, two-dimensional sheets of epithelial
cells are remodeled into three-dimensional organs (Trinkaus,
1984). This process is guided by soluble and membrane-associated
ligand-receptor interactions that activate intracellular signaling
pathways, which in turn control nuclear determinants such as Hox,
ETS, ZnF, bHLH or Forkhead transcription factors. Organogenesis can
be divided into four conceptual steps that are compartmentalized
in time: (1) speciﬁcation of the precursor cells that are competent
to differentiate, (2) induction of distinct cell fates among the
precursor cells, (3) proliferation of the precursor cells to generate
the required number of cells of the different types and (4) terminal
differentiation and spatial rearrangement of post-mitotic cells
during the morphogenesis phase. However, we currently lack a
clear understanding of the mechanisms that coordinate these
different steps of organogenesis.
The hox genes encode homeobox domain-containing
transcription factors that play diverse roles during organogenesis
(Rezsohazy et al., 2015). Originally discovered as the determinants
of segment identity in the Drosophila embryo (Lewis, 1978), hox
genes control a broad range of cellular functions including cell
proliferation and tissue morphogenesis. Moreover, de-regulated
expression of hox genes has also been linked to the formation of
acute myeloid (AML) and lymphoid leukemia (ALL) in humans
(Celetti et al., 1993; Soulier et al., 2005). HOX proteins form het-
erodimers with their PBX or MEIS family co-factors to activate
target genes that carry distinct DNA motifs in their enhancers
(Rezsohazy et al., 2015). However, there exists no comprehensive
picture of the direct hox target genes that mediate the different
aspects of hox gene function.
The development of the Caenorhabditis elegans vulva, the egg-
laying organ of the hermaphrodite, is an excellent model to in-
vestigate how cell fate speciﬁcation, cell proliferation and organ
morphogenesis are coordinated in time and space (reviewed by
Schindler and Sherwood (2012), Schmid and Hajnal (2015) and
Sternberg (2005)). Vulval fate speciﬁcation involves the combined
action of the conserved Wingless (WNT), EGFR/RAS/MAPK and
DELTA/NOTCH signaling pathways. Towards the end of the ﬁrst
larval stage (L1), twelve epidermal Pn.p cells align along the
ventral midline of the animal. A WNT signal from a group of tail
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Fig. 1. The VPCs in lin-39mutants are partially sensitive to the inductive AC signal but do not proliferate. (A) Signaling pathways and transcription factor network controlling
VPC differentiation and proliferation. During the L2 stage, Wnt signaling maintains basal LIN-39 levels, while LIN-31 and LIN-1 repress lin-39 transcription. The heterochronic
LIN-28 protein as well as LIN-31 activate cki-1 expression to arrest the VPCs in the G1 phase of the cell cycle. (B) Towards the end of the L2 stage, the inductive LIN-3 EGF
signal activates the LET-23 EGFR pathway in the 1° VPC (P6.p), resulting in the inactivation of the LIN-1/LIN-31 complex through MAPK phosphorylation. Together with the
fading in LIN-28 levels, this causes a reduction in CKI-1 expression, permitting the VPCs to enter S-phase. At the same time, elevated LIN-39 levels activate LAG-2 expression
to induce lateral LIN-12 NOTCH signaling in the adjacent 2° VPCs (P5.p & P7.p). LIN-12 NOTCH signaling then inhibits LET-23 signaling and induces the 2° vulval fate.
(C) Expression of a functional LET-23::GFP reporter in P6.p of an eff-1(lf) single and (C′) an eff-1(lf); lin-39(n1760) double mutant at the late L2/early L3 stage. (D) Expression
of a functional LIN-12::GFP reporter on the apical membranes of P5.p through P7.p in an eff-1(lf) single mutant and (D′) loss of LIN-12::GFP expression in an eff-1(lf); lin-39
(n1760) double mutant. (E) Vulval invaginations in lin-39(lf) mutants require the inductive LIN-3 signal. For each genotype, the percentage of animals developing a vulval
invagination and (F) the average number of cells per invagination in those animals that formed an invagination are shown (e.g. in 18 out of the 173 eff-1(lf); lin-39(n1760)
double mutants analyzed). The number of animals analyzed for each genotype is shown in brackets. The error bars represent the standard error of the mean (s.e.m.).
Statistical signiﬁcance was analyzed with a Fisher's exact probability test; * signiﬁes po0.05 and *** po0.001.
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cells induces the expression of the hox gene lin-39 in six Pn.p cells
in the mid-body region (P3.p through P8.p), which become the
vulval precursor cells (VPCs) (Eisenmann, 2005; Eisenmann et al.,
1998). These six VPCs are competent to differentiate into one of
two alternate vulval cell fates. (Though, P3.p, which is furthest
away from the source of the WNT signal, adopts a VPC fate only in
around 50% of the animals.) LIN-39 prevents the VPCs from fusing
to the surrounding syncytial hypodermis (hyp7) by repressing, via
the GATA transcription factors EGL-18 and ELT-6, the expression of
the eff-1 fusogen (Koh et al., 2002; Shemer and Podbilewicz, 2002,
Fig. 1A). Moreover, the LIN-1 ETS and LIN-31 Forkhead transcrip-
tion factors inhibit vulval differentiation by repressing the ex-
pression of lin-39 and of the NOTCH ligand lag-2 (Guerry et al.,
2007; Wagmaister et al., 2006b; Zhang and Greenwald, 2011).
Towards the end of the L2 stage, an inductive signal from the
gonadal anchor cell (AC) selects the nearest VPC (P6.p) to adopt a
primary (1°) vulval fate (Sternberg, 2005, Fig. 1B). The AC secretes
the LIN-3 growth factor, which is homologous to the mammalian
epidermal growth factor (EGF), and activates the EGF receptor
homolog LET-23 in the VPCs. Downstream of LET-23, the canonical
RAS/MAPK pathway controls the activity of transcription factors
that specify the 1° cell fate (Sundaram, 2006). Activated MAPK
phosphorylates the LIN-1 ETS and LIN-31 Forkhead transcription
factors, which relieves their inhibitory effect on lin-39 expression
and permits vulval differentiation (Miller et al., 1993; Tan et al.,
1998). Since the 1° VPC P6.p receives most of the inductive LIN-3
signal, it exhibits the highest LIN-39 expression (Maloof and
Kenyon, 1998). LIN-39 plays essential roles during and after vulval
fate speciﬁcation. For example, during vulval fate speciﬁcation LIN-
39 induces the expression of the lin-12 notch receptor and its li-
gand lag-2 (Regős et al., 2013; Takács-Vellai et al., 2007, Fig. 1B).
Activation of the LIN-12 NOTCH receptor in P5.p and P7.p speciﬁes
the 2° and inhibits the 1° fate (Berset et al., 2001; Sundaram, 2006;
Yoo et al., 2004). During the morphogenesis phase, LIN-39 pro-
motes the proliferation of the vulval cells (Shemer and Podbile-
wicz, 2002) and activates the expression of vab-23, which is es-
sential for the formation of the vulval toroids (Pellegrino et al.,
2011).
One aspect of vulval development that is less understood is the
control of VPC proliferation. The heterochronic genes lin-14 and
lin-28 together with the MAPK targets lin-31 and lin-1 are required
to arrest the VPCs during the L2 stage in the G1 phase of the cell
cycle, in part by inducing the expression of the CDK inhibitor CKI-1
(Clayton et al., 2008; Hong et al., 1998; Hoyos et al., 1996; van den
Heuvel, 2005, Fig. 1A). lin-39, on the other hand, is necessary for
VPC proliferation after vulval induction, though the exact role of
lin-39 in cell cycle control has not been investigated (Shemer and
Podbilewicz, 2002). Moreover, it is unclear if and how the activity
of the EGFR and NOTCH signaling pathways coordinate cell cycle
progression with vulval induction to maintain the proliferation of
the differentiating vulval cells. Here, we show that the hox gene
lin-39 performs two distinct functions in order to link VPC fate
speciﬁcation and proliferation. First, LIN-39 maintains the VPCs
competent to proliferate by directly inducing the expression of the
core cell cycle regulators, such as cye-1 cyclinE and cdk-4. Second,
LIN-39 activates the lateral NOTCH signaling pathway, which
overcomes the LIN-31 mediated repression of the cell cycle.
2. Materials and methods
2.1. C. elegans methods and strains
All strains used were derived from the Bristol strain N2. Ani-
mals were cultivated under standard conditions at 20 °C as de-
scribed in (Brenner, 1974) unless speciﬁed. The mutations used in
this study have been previously described and are listed below
according to their linkage groups. To construct the different mu-
tant combinations standard genetic methods were used.
Alleles used: LGII: lin-31(n301) (Miller et al., 1993), cdc-14
(he141) (Saito et al., 2004), lin-31(cp1) (Dickinson et al., 2013), eff-1
(ok1021) (Podbilewicz et al., 2006); LGIII: lin-39(n1760) (Clark
et al., 1993); LGIV: lin-3(e1417) (Hwang and Sternberg, 2004), lin-1
(e1777) (Ferguson and Horvitz, 1985).
Transgenes used: maIs113[Pcki-1::gfp, dpy-20(þ)] (Hong et al.,
1998), zhIs1[lin-39::gfp] (Szabó et al., 2009), zhIs038[let-23::gfp,
unc-119(þ)] (Haag et al., 2014), arIs82[lin-12::gfp; unc-4(þ)]
(Shaye and Greenwald, 2002), zhIs80[Pcye-1::gfp], zhIs86[Pcye-1::
gfp, unc-119(þ)], zhIs87[Pcye-1ΔHBS1::gfp, unc-119(þ)], zhIs88
[Pcye-1ΔHBS2::gfp, unc-119(þ)], zhIs89[Pcye-1ΔHBS1ΔHBS2::gfp,
unc-119(þ)], zhEx535[Pcdk-4::gfp] (all this study), zhEx500[Pbar-1::
nicd::gfp, unc-119(þ)] (Nusser-Stein et al., 2012).
2.2. Plasmids and transgenic lines
Plasmid pDR8 (Pcye-1::gfp) was made by cloning the promoter
and the ﬁrst part of the coding region (942 to þ1375) in frame
with the gfp cassette into the HindIII and SalI sites of plasmid
pPD95.75 (gift from Andrew Fire, Stanford University School of
Medicine). pDR10 (Pcdk-4::gfp) was made by introducing the cdk-4
promoter region including the two annotated isoforms (800 to
þ1588) into the BamHI and SphI sites of plasmid pPD96.04 (a gift
from Andrew Fire). pDR11 (Pcye-1::gfp, unc-119(þ)) was built by
cloning a 4 kb SpeI fragment containing the Pcye-1::gfp reporter
from the plasmid pDR8 into the SpeI site of the mosSCI vector
pCFJ151 (Frøkjær-Jensen et al., 2008). pDR12 (Pcye-1ΔHBS1::gfp,
unc-119(þ)), pDR13 (Pcye-1ΔHBS2::gfp, unc-119(þ)) and pDR15
(Pcye-1ΔHBS1ΔHBS2::gfp, unc-119(þ)) were obtained by site-di-
rected mutagenesis of the plasmid pDR11 introducing the muta-
tions described in the results section. The primers used for plas-
mid constructions are listed in Table S1.
Worms carrying extra-chromosomal arrays were generated by
microinjection of puriﬁed plasmids into the syncytial gonads of
young adult worms (Mello et al., 1991). All constructs were in-
jected at a concentration of 50 ng/ml. For zhIs80 and zhEx535 we
used pCFJ90 (Pmyo-2::mcherry) as transformation marker at a
concentration of 2.5 ng/ml (Frøkjær-Jensen et al., 2008). zhIs80 was
integrated through gamma irradiation to an unknown location in
the genome. The total concentration of DNA was adjusted to
150 ng/ml by adding the plasmid pBluescript-KS. For the genera-
tion of the mosSCI lines (Frøkjær-Jensen et al., 2008), zhIs86 to
zhIs89, we injected the plasmids pDR11, pDR12, pDR13 or pDR15
together with the markers pCFJ90 (Pmyo-2::mcherry) at a con-
centration of 2.5 ng/ml, pCFJ104 (Pmyo-3::mcherry) at a con-
centration of 5 ng/ml and pGH8 (Prap::mcherry) at a concentration
of 10 ng/ml, together with the Mos1 transposase plasmid pJL43.1 at
a concentration of 50 ng/ml.
2.3. Microscopy and image analysis
Animals were mounted on 4% agarose pads in 20 mM tetra-
misole hydrochloride in water. The vulval induction index was
scored as described (Berset et al., 2001). To obtain synchronized
late L2 larvae, oocytes were isolated by hypochlorite treatment of
gravid adults, allowed to hatch in the absence of food for 24 h to
obtain arrested L1 larvae that were transferred to plates contain-
ing OP50 bacteria and grown until they had reached the late L2/
early L3 stage. For S-phase arrest, hydroxyurea was added to
synchronized L2 larvae at a concentration of 40 mM as described
(Ambros, 1999; Berset et al., 2001). The vulval invaginations and
the number of cells per invagination were counted using Nomarski
optics in a Leica DMRA microscope equipped with a CCD camera
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(Hamamatsu ORCA-ER) controlled by the Openlab 5 software
(Improvision). To quantify GFP reporter expression, a calibrated
ﬂuorescent light source (X-Cite exacte, Excelitas Technologies
Corp) was used on the same microscope. To compare GFP in-
tensities in the eff-1(lf) and eff-1(lf); lin-39(lf) backgrounds, images
were acquired under the same illumination conditions and ac-
quisition settings. Fluorescent signal intensities in the VPC nuclei
were quantiﬁed using the Fiji software as described (Nusser-Stein
et al., 2012; Schindelin et al., 2012).
2.4. ChIP-Q-PCR analysis
Chromatin extracts were prepared from 100 ml mixed-stage
liquid cultures of animals carrying the zhIs1[lin-39::gfp] and zhIs89
[Pcye-1ΔHBS1ΔHBS2::gfp] arrays as described (Pellegrino et al.,
2011). As negative controls, extract from animals carrying only
zhIs89[Pcye-1ΔHBS1ΔHBS2::gfp] were prepared and processed in
parallel. Cross-linking was done with 1% paraformaldehyde for
20 min at room temperature. LIN-39::GFP bound chromatin was
precipitated using GFP-Traps antibodies (Chromotek) as described
by Pellegrino et al. (2011) with the following modiﬁcation: Ex-
tracts were pre-cleared by incubation with Dynabeads (10 ml per
sample) before adding GFP-Traps beads (20 ml per 4–5 mg of total
protein in the extracts). After reverse cross-linking, binding of LIN-
39::GFP to the different sites was quantiﬁed by Q-PCR using an ABI
Prism 7900HT thermocycler with the MESA Green mastermix plus
(Eurogentec) and primers speciﬁc for the wild-type HBS in en-
dogenous cye-1 and the mutant HBS in the zhIs89 reporter (for the
sequences of the primer used see Table S1). For each measure-
ment, the signal was ﬁrst normalized to the signal obtained from
the input DNA (% input). To calculate the speciﬁc enrichment, the %
input value obtained from the zhIs1[lin-39::gfp]; zhIs89[Pcye-
1ΔHBS1ΔHBS2::gfp] strain was divided by the % input value ob-
tained from the zhIs89[Pcye-1ΔHBS1ΔHBS2::gfp] negative control
strain. In addition to the Q-PCR assays in the HBS regions, we used
a primer pair in the 3′ UTR of cye-1 and a primer pair spanning the
cye-1::gfp fusion in the zhIs89 reporter, respectively. The data in
Fig. 3H show the average ratios obtained in three independent
experiments.
2.5. Statistical analysis
t-tests for independent samples were used to determine the
statistical signiﬁcance of differences. Where speciﬁed the Fisher's
exact probability test was performed. In all ﬁgures, * indicates
po0.05, ** po0.005 and *** po0.001. Statistical analysis of the
cye-1::gfp expression intensities is shown in Table S2.
3. Results
3.1. The VPCs in lin-39 mutants are partially sensitive to the in-
ductive LIN-3 signal but they do not proliferate
Shemer et al. (Shemer and Podbilewicz, 2002) originally re-
ported that in lin-39(lf) mutants carrying in addition a loss-of-
function (lf) mutation in eff-1 to prevent the fusion of the Pn.p cells
with the hypodermis, the Pn.p cells remained as polarized epi-
thelial cells, but they failed to proliferate. Despite the loss of Pn.p
cell proliferation, the proximal cells P5.p, P6.p and P7.p occasion-
ally formed a vulval invagination containing three to four cells,
indicating that Pn.p cells lacking lin-39 can differentiate as long as
they are maintained as polarized epithelial cells. These observa-
tions indicated that lin-39 plays a pivotal role as a regulator of cell
cycle in the VPCs (Shemer and Podbilewicz, 2002).
Building on these ﬁndings, we ﬁrst investigated the capability
of the Pn.p cells in eff-1(lf); lin-39(lf) double mutants to receive the
inductive LIN-3 EGF or lateral LIN-12 NOTCH signal. A functional
reporter for the let-23 egf receptor (Haag et al., 2014) was ex-
pressed in P6.p in around 20% of eff-1(lf); lin-39(lf) double mutants
(n¼22) as opposed to 80% of eff-1(lf) single mutants (n¼20),
which we used as control strain throughout this study (Fig. 1C,C′).
By contrast, the expression of a LIN-12::GFP reporter (Shaye and
Greenwald, 2002), which was localized on the apical surface of the
VPCs in all eff-1(lf) animals examined, was not detectable in eff-1
(lf); lin-39(lf) double mutants (Fig. 1D,D′) (n¼20 for each geno-
type). Thus, the Pn.p cells in lin-39(lf) mutants may remain par-
tially competent to receive the inductive AC signal.
We observed a vulval invagination in the mid-body region
underneath the AC in 11% of eff-1(lf); lin-39(lf) double mutants
(Fig. 1E and Table S3). While the invaginations of eff-1(lf) single
mutants always contained 22 differentiated vulval cells as in wild-
type larvae, the invaginations in the eff-1(lf); lin-39(lf) double
mutants on average contained 3.8 cells, as these invaginations
were mostly formed by three undivided Pn.p cells (Fig. 1F and
Table S3). To test if the inductive LIN-3 EGF signal plays a role in
inducing vulval differentiation in the absence of LIN-39, we in-
troduced the lin-3(e1417) allele, which speciﬁcally reduces lin-3 egf
expression in the AC (Hwang and Sternberg, 2004), into the eff-1
(lf); lin-39(lf) background. Even though the lin-3(e1417) allele does
not completely block vulval induction (Table S3), none of the eff-1
(lf); lin-39(lf); lin-3(lf) triple mutants examined developed a vulval
invagination (Fig. 1C,D and Table S3).
We conclude that those Pn.p cells, which formed a vulval in-
vagination in eff-1(lf); lin-39(lf) double mutants (11% of the cases),
had responded to the inductive LIN-3 EGF signal, but they did not
proliferate. Thus, lin-39 is essential to promote VPC proliferation
even though Pn.p cells lacking lin-39 remain partially sensitive to
the inductive LIN-3 EGF signal.
3.2. lin-39 induces the expression of the cell cycle regulators cye-1,
cki-1 and cdk-4
To characterize the role of LIN-39 in regulating VPC prolifera-
tion, we explored the modENOCODE data (Niu et al., 2011) and
searched for predicted LIN-39 binding sites in the 5′ regulatory
regions or in introns of genes encoding known cell cycle reg-
ulators. We found predicted LIN-39 binding sites in at least 17
regulators of the cell cycle; these are cki-1, cdk-4, cye-1, cdc-14, cdk-
1, cdk-7, lin-35, eﬂ-1, lin-9, mat-1, mrt-2, cul-1, san-1, mdf-1, wee-1.3,
lin-23 and lin-36 (van den Heuvel, 2005). We focussed on reg-
ulators of the G1 to S-phase transition because the VPCs arrest in
the G1 phase during the L2 stage and progress into the S phase
after adopting their fates at the late L2/ early L3 stage. We ob-
served strong LIN-39 binding sites in the genes encoding the CDK
kinase CDK-4 (Park and Krause, 1999) and in the G1/S phase cyclin
CYE-1 (Gleason et al., 2000, Fig. S1 and Fig. 3A). Weaker binding
sites were also observed in the cki-1 locus, which encodes a CDK
inhibitor of the p21 family (Hong et al., 1998, Fig. S1).
To investigate whether lin-39 controls the expression of these
G1/S-phase regulators in the VPCs, we compared the expression
patterns of transcriptional gfp reporters in eff-1(lf) single versus
eff-1(lf); lin-39(lf) double mutants that were synchronized at the
mid to late L2 stage, shortly before the VPCs normally begin to
proliferate (see Section 2). For cdk-4, we constructed a reporter
that includes the two alternative ﬁrst exons and 1 kb of 5′ reg-
ulatory sequences containing the predicted LIN-39 binding site
and all the previously identiﬁed regulatory elements (Brodigan
et al., 2003). The frequency of VPCs expressing Pcdk-4::gfp was
reduced from nearly 50% in eff-1(lf) single mutants to less than 10%
in eff-1(lf); lin-39(lf) double mutants (Fig. 2A,D). Similarly, the
expression of a Pcki-1::gfp reporter containing 8 kb of 5′ regulatory
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sequences and the endogenous 3′ UTR (Hong et al., 1998) was
reduced from around 70% GFP positive VPCs in single to fewer
than 20% in eff-1(lf); lin-39(lf) double mutants (Fig. 2B,D). To
analyze cye-1 expression, we generated a Pcye-1::gfp reporter
(zhIs80), in which a gfp cassette was fused in frame into the third
exon, such that both predicted LIN-39 binding sites were included
as well as the previously described domains that are necessary for
cye-1 expression (Brodigan et al., 2003, Fig. 3A). Since the Pcye-1::
gfp reporter is only transiently expressed in the VPCs at the late
G1/early S-phase, we exposed late L2 larvae for four hours to hy-
droxyurea (HU) to arrest their cell cycle in the early S-phase before
analyzing Pcye-1::gfp expression (see Section 2). With this proce-
dure we were able to detect cye-1::gfp expression in around 20% of
the VPCs in eff-1(lf) single mutants (Fig. 2C,D). Similar to the other
cell cycle regulators, Pcye-1::gfp expression was strongly reduced
in eff-1(lf); lin-39(lf) double mutants.
In summary, the transcriptional reporter analysis indicated that
lin-39 is necessary for the expression of cdk-4, cki-1 and cye-1 in
Fig. 2. Reduced cdk-4, cki-1and cye-1reporter expression in lin-39mutants and re-activation in lin-31mutants. (A) Expression of the transcriptional Pcdk-4::gfp, (B) Pcki-1::gfp
and (C) Pcye-1::gfp reporters. The ﬁrst rows show the Nomarski images of (from left to right) eff-1(ok1021) single, eff-1(ok1021); lin-39(n1760) double and lin-31(n301) eff-1
(ok1021); lin-39(n1760) triple mutants. Pcdk-4::gfp and Pcki-1::gfpwere analyzed in mid L2 larvae (26 h after L1 arrest); Pcye-1::gfp expression was scored in S-phase arrested
early L3 larvae by exposing mid L2 larvae (26 h after L1 arrest) for 4 h to 40 mM hydroxyurea (see Section 2). The arrowheads point at the positions of the VPC nuclei and the
two smaller arrows in the right panel of (A) indicate duplicated VPCs. The scale bar in (C) is 10 mm. (D) Percentage of VPCs expressing the cell cycle reporters in the different
genetic backgrounds shown in (A) through (C). The number of VPCs analyzed for each genotype is shown in brackets. Statistical signiﬁcance was analyzed with a Fisher's
exact probability test; * signiﬁes po0.05 and *** po0.001.
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the VPCs of L2 larvae. Since the modENCODE project detected LIN-
39 binding sites in several additional -positive and negative- cell
cycle regulators, LIN-39 may act as a permissive factor that
maintains the expression of the cell cycle machinery.
3.3. LIN-39 induces cye-1 expression through a non-canonical HOX
Binding Site
Even though the modENCODE data indicated the presence of
LIN-39 HOX binding sites (HBS) in several cell cycle regulators, we
could not identify the canonical HOX/PBX consensus motif
TGATNNAT (Mann and Affolter, 1998) within the predicted binding
regions. However, by searching for a common motive within the
LIN-39 binding regions of cell cycle regulators and by ﬁltering
them using the syntenic regions in the Caenorhabditis briggsae and
Caenorhabditis remanei genomes, we identiﬁed conserved se-
quence blocks containing the motif TTTG(A/T)AT(T/C)T, which
appears to be diverged from the canonical HOX/PBX binding motif
TGATNNAT (Fig. 3A and Fig. S1).
To test if LIN-39 directly activates cye-1 expression through
these non-canonical HBSs, we generated four variants of the cye-
1::gfp reporter and integrated single copies of each reporter at a
deﬁned location on chromosome II using the mosSCI technique
(Frøkjær-Jensen et al., 2008): a wild-type reporter with both HBSs
intact (zhIs86); the ΔHBS1 reporter (zhIs87), in which the HBS
upstream of the promoter had been mutated from TTTGAATCT to
TTTCCCCCT, the ΔHBS2 reporter (zhIs88), in which the HBS in the
second intron had been mutated from TTTGTATTT to TTTCCCCTT,
and the ΔHBS1ΔHBS2 reporter (zhIs89), in which both HBSs had
been mutated (Fig. 3B). We then measured for each reporter the
relative cye-1::gfp signal intensity in the VPCs of early L3 larvae.
Expression of the wild-type reporter was robust and signiﬁcantly
stronger in the 1° VPCs than in the 2° VPCs (Fig. 3C,G and Table S2
for statistical analysis). The ΔHBS1 reporter showed overall re-
duced and equal expression levels in the 1° and 2° VPCs (Fig. 3D,
G). By contrast, the ΔHBS2 reporter exhibited only a slight
Fig. 3. LIN-39 regulates cye-1 expression via conserved HBS motifs. (A) The top graph shows the LIN-39 ChIP read counts in the cye-1 genomic region as reported by
modENCODE (Niu et al., 2011). The sequence conservation between the C. elegans, C. briggsae and C. remanei cye-1 loci is shown in the graphs underneath with the sequence
alignments of the two LIN-39 binding sites containing conserved HBS motifs. (B) Structure of the wild-type cye-1 reporter and the mutations in the two HBS motifs. (C-F′)
Expression pattern of the wild-type cye-1::gfp reporter and the ΔHBS1 and ΔHBS2 single and double mutants in the VPCs of early L3 larvae. The arrowheads point at the
positions of the VPC nuclei, and the scale bar in (F′) is 10 mm. (G) Quantiﬁcation of wild-type and mutant cye-1::gfp reporter expression in P5.p through P7.p in early L3 larvae.
All values were normalized to the average GFP intensity measured with the wild-type reporter in P6.p. A statistical analysis of the data is shown in supplementary Table S1.
(H) Location of the PCR primers used for ChIP-Q-PCR analysis of endogenous cye-1 on LGI and the cye-1ΔHBS1ΔHBS2 reporter on LGII. Grey primers indicate genotype
speciﬁc binding. (I) Enrichment of LIN-39::GFP at the HBS sites of endogenous cye-1 (dark grey columns) and the ΔHBS1ΔHBS2 reporter (light grey columns). The speciﬁc
enrichment was calculated as described in Section 2, and the average values obtained in three independent experiments are shown. The error bars represent the standard
error of the mean (s.e.m.).
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reduction in the expression levels and maintained the bias to-
wards 1°-speciﬁc expression (Fig. 3E,G). Finally, the expression of
the ΔHBS1ΔHBS2 reporter was further reduced when compared to
either single mutant ΔHBS reporter (Fig. 3F,G). Thus, the two HBS
cooperatively induce cye-1 expression in the VPCs. Though, the
HBS1 site seems to introduce a 1° lineage-speciﬁc bias and overall
contributes to a greater extent than the HBS2 site. This 1°-lineage
bias could be due to the higher lin-39 levels in the 1° VPC (Maloof
and Kenyon, 1998).
To conﬁrm the binding of LIN-39 to the HBS motifs in cye-1, we
performed chromatin immunoprecipitation (ChIP) experiments
combined with quantitative real-time PCR (Q-PCR) analysis as
described previously (Pellegrino et al., 2011, see also Section 2). By
using chromatin extracts of mixed-stage transgenic animals car-
rying a single copy of the ΔHBS1ΔHBS2 reporter integrated on
chromosome II and a functional lin-39::gfp transgene, we could
directly compare LIN-39 binding to the wild-type (endogenous)
and the mutant (transgenic) HBS motifs in the same chromatin
preparation. For this purpose, we designed PCR primer pairs spe-
ciﬁcally amplifying either of the two wild-type HBSs in en-
dogenous cye-1 on chromosome I or the mutant HBSs in the
ΔHBS1ΔHBS2 reporter on chromosome II (Fig. 3H).
Q-PCR analysis of LIN-39::GFP ChIP revealed a nearly two-fold
enrichment of LIN-39 binding at the wild-type HBS1 site in the
endogenous cye-1 locus compared to the ChIP from control ani-
mals lacking the lin-39::gfp transgene, conﬁrming the speciﬁc LIN-
39 binding to the wild-type HBS1 (Fig. 3I shows the average values
of three completely independent experiment). On the other hand,
LIN-39 was only slightly enriched (around 1.2 fold) at the mutant
ΔHBS1 in the cye-1 reporter on chromosome II. Despite the clear
LIN-39 peak observed by modENCODE at the HBS2 in the second
intron of cye-1, we detected only a very slight enrichment of LIN-
39::GFP at this site when compared to negative control ChIP
lacking LIN-39::GFP (Fig. 3I). This may be due to a much weaker or
more transient binding of LIN-39 to the HBS2 motif.
Taken together, the results of the ChIP analysis are consistent
with the relatively mild effect of the ΔHBS2 mutation on Pcye-1::
gfp expression and support the conclusion that the HBS1 site is the
main LIN-39 response element in cye-1. Given the sequence con-
servation in the LIN-39 binding sites in the cki-1 and cdk-4 genes
detected by modENCODE, it seems likely that LIN-39 also binds to
the HBS motifs in other cell cycle regulator genes.
3.4. The lin-31 forkhead transcription factor inhibits Pn.p cell
proliferation
Since LIN-39 is expressed in the VPCs immediately after they
are born at the late L1 stage (Clark et al., 1993; Wagmaister et al.,
2006a), we hypothesized that additional factors should exist to
counteract LIN-39 activity and block proliferation until the vulval
cell fates have been speciﬁed towards the end of the L2 stage. A
complex of the LIN-1 ETS and LIN-31 Forkhead transcription fac-
tors plays an important role in inhibiting vulval differentiation and
maintaining VPC quiescence (Jacobs et al., 1998; Tan et al., 1998). In
particular, LIN-1 and LIN-31 repress the transcription of lin-39 and
promote the expression of cki-1 (Clayton et al., 2008; Guerry et al.,
2007; Wagmaister et al., 2006b). To test if LIN-31 or LIN-1 repress
VPC proliferation in addition to inhibiting lin-39 and promoting
cki-1 expression, we examined Pn.p cell proliferation in eff-1(lf)
lin-31(lf); lin-39(lf) and eff-1(lf); lin-39(lf); lin-1(lf) triple mutants
(Fig. 4A). To quantify proliferation, we counted the frequency of
animals developing at least one invagination at the L4 stage
(Fig. 4B), as well as the average number of differentiated cells per
invagination among the animals with invaginations (Fig. 4C). Due
to the variable position of the Pn.p cells and their descendants in
eff-1(lf); lin-39(lf) double mutants, it was impossible to
unambiguously identify the individual cell lineages. Therefore,
supplementary Table S3 shows the relative positions of the in-
vaginations in the different genotypes, which we scored by de-
ﬁning 6 zones along the anterior-posterior axis as described in the
table legend.
The lin-31(lf) but not the lin-1(lf) mutation rescued the pro-
liferation defect of eff-1(lf); lin-39(lf) animals (Fig. 4A). In eff-1(lf)
lin-31(lf); lin-39(lf) triple mutants, we observed an increase in the
frequency of Pn.p cells forming an invagination (Fig. 4B) as well as
in the number of differentiated cells per invagination (Fig. 4C). In
contrast to lin-31(lf), the lin-1(lf) mutation did not increase the
frequency of invaginations or the number of cells per invagination
in the eff-1(lf); lin-39(lf) background (Fig. 4 and Table S3). More-
over, we did not observe an additional increase in the frequency of
invaginations in eff-1(lf) lin-31(lf); lin-39(lf); lin-1(lf) quadruple
mutants, and the average number of cells per invagination was not
signiﬁcantly increased compared to eff-1(lf) lin-31(lf); lin-39(lf)
triple mutants (Fig. 4B,C and Table S3).
While the invaginations in eff-1(lf); lin-39(lf) double mutants
always formed in the mid body region underneath the AC, the
invaginations in eff-1(lf) lin-31(lf); lin-39(lf) and eff-1(lf); lin-39(lf);
lin-1(lf) triple mutants were frequently shifted towards the pos-
terior body region, suggesting an AC-independent induction of
vulval differentiation (Fig. 4A and Table S3). Moreover, the lin-31
(lf) mutation not only caused Pn.p cell proliferation in the absence
of lin-39, but it also re-activated the expression of the cell cycle
reporters. Especially, the frequency of Pn.p cells expressing cye-1::
gfp and cdk-4::gfp was signiﬁcantly increased in eff-1(lf) lin-31(lf);
lin-39(lf) triple compared to and eff-1(lf); lin-39(lf) double mutants
(Fig. 2A,C,D). On the other hand, the expression of cki-1::gfp was
not restored by the lin-31(lf) mutation (Fig. 2B,D) because LIN-31
positively regulates cki-1 expression (Clayton et al., 2008). We
therefore tested if a loss-of-function mutation in the CKI-1 acti-
vator cdc-14 (Roy et al., 2011; Saito et al., 2004) was sufﬁcient to
rescue the Pn.p proliferation defect of eff-1(lf); lin-39(lf) mutants.
However, the inactivation of CKI-1 through a cdc-14(lf) mutation
did not induce Pn.p cell proliferation in the eff-1(lf); lin-39(lf)
background (Table S3 and data not shown).
Taken together, these results indicate that LIN-31 inhibits cell
cycle progression independently of LIN-39 and LIN-1. For this
purpose, LIN-31 induces cki-1 and represses cdk-4 and cye-1 ex-
pression to arrest the VPCs in the G1 phase. During vulval induc-
tion, phosphorylation of LIN-31 by the MAPK likely inactivates this
repressor function of LIN-31 and releases the inhibition of the VPC
cycle (Tan et al., 1998).
3.5. LIN-12 NOTCH signaling promotes VPC proliferation in parallel
with LIN-31
Neither lin-12 notch nor its ligand lag-2 delta are expressed in
the VPCs of lin-39(lf)mutants (Fig. 1D and Regős et al., 2013; Zhang
and Greenwald, 2011). We thus tested if the VPC proliferation
defect of eff-1(lf); lin-39(lf) double mutants could be rescued by
forced activation of the NOTCH signaling pathway. For this pur-
pose, we introduced a transgene expressing the intracellular LIN-
12 domain (NICD) under the control of the bar-1 promoter, which
is active in all VPCs (Pbar-1::nicd::gfp) (Nusser-Stein et al., 2012). In
the eff-1(lf) background, the Pbar-1::nicd::gfp transgene caused
ectopic 2° fate speciﬁcation in all VPCs except for P6.p, which was
induced by the AC signal to adopt a 1° fate. Similar to the lin-31(lf)
mutation, the Pbar-1::nicd::gfp transgene restored VPC proliferation
and caused the formation of ectopic vulval invaginations in the eff-
1(lf); lin-39(lf) background (Fig. 4 and Table S3). Furthermore, we
observed a similar shift of the vulval invaginations towards the
posterior body region as described above for the lin-31(lf) muta-
tion (Fig. 4A and Table S3).
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Fig. 4. Suppression of the lin-39 proliferation defect by lin-31(lf) or by NOTCH signaling. (A) Nomarski image of representative animals for each genotype are shown. Arrows
indicate the position of the invaginations. (B) Percentage of animals with invaginations at the L4 stage. Numbers in brackets indicate the number of animals analyzed for each
genotype. (C) Average number of cells per invagination in those animals developing at least one invagination. Error bars indicate the standard error of the mean (s.e.m.).
Statistical signiﬁcance was analyzed with a T-test; n signiﬁes po0.05, nnsigniﬁes po0,005 and nnn po0.001.
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We have previously reported that the non-phosphorylated
form of LIN-1 is required for certain aspects of 2° cell fate execu-
tion acting downstream of the NOTCH pathway, indicating a dual
function of LIN-1 depending on its phosphorylation status (Far-
ooqui et al., 2012). We therefore tested if LIN-1 also acts down-
stream of the NOTCH pathway to promote the cell cycle progres-
sion. To this aim, we crossed the lin-1(lf) allele e1777 into the eff-1
(lf); lin-39(lf); Pbar-1::nicd::gfp strain (Fig. 4A). lin-1(lf) did not sig-
niﬁcantly suppress the Pn.p cell proliferation induced by the Pbar-
1::nicd::gfp transgene (Fig. 4B,C and Table S3). Thus, the activation
of NOTCH signaling promotes VPC proliferation independently of
LIN-1.
One possible scenario is that NOTCH signaling activates VPC
proliferation by inactivating LIN-31, for example by inducing LIN-
31 phosphorylation. Alternatively, NOTCH signaling may bypass
the LIN-31-mediated repression of the cell cycle and induce VPC
proliferation independently of LIN-31. To distinguish between
these two scenarios, we examined the epistatic interaction be-
tween lin-12 notch(gf) and the constitutively active, phosphoryla-
tion-deﬁcient lin-31(cp1) mutant, in which the four threonine re-
sidues that are phosphorylated by the MAPK (T145, T200, T218
and T220) had been mutated into alanine (Dickinson et al., 2013).
lin-31(cp1) completely suppressed the residual proliferation oc-
curring in eff-1(lf); lin-39(lf) double mutants, as none of the eff-1
(lf) lin-31(cp1); lin-39(lf) triple mutants examined developed a
vulval invagination (Fig. 4 and Table S3). Thus, lin-31(cp1) acts as a
repressor of VPC proliferation. If the NOTCH pathway activates VPC
proliferation by inactivating LIN-31, then the lin-31(cp1) mutation
should suppress VPC proliferation in eff-1(lf); lin-39(lf); Pbar-1::
nicd::gfp animals. However, the lin-31(cp1) allele had no effect on
VPC proliferation in the eff-1(lf); lin-39(lf) Pbar-1::nicd::gfp back-
ground, as neither the frequency of invaginations nor the number
of cells per invagination were signiﬁcantly reduced (Fig. 4 and
Table S3).
Taken together, the epistasis analysis indicates that NOTCH
signaling promotes VPC proliferation independently of LIN-1 and
of LIN-31 phosphorylation. We conclude that NOTCH signaling
induces VPC proliferation via a separate pathway acting in parallel
with LIN-1 and LIN-31.
4. Discussion
hox genes encode homeodomain transcription factors that
control cell proliferation in a variety of tissues in different organ-
isms (Hombria and Lovegrove, 2003; Rezsohazy et al., 2015).
Known examples include cell proliferation during insect and ver-
tebrate limb development (Cohn et al., 1997; Mahfooz et al., 2004),
tail regeneration in the zebraﬁsh (Thummel et al., 2007) or
hematopoietic stem cell expansion (Schiedlmeier et al., 2007).
Moreover, de-regulated hox gene expression caused by chromo-
somal translocations or other mutations has been observed in
different types of leukemia (Schiedlmeier et al., 2007). In most of
these cases the HOX proteins were found to control proliferation
indirectly by inducing secondary target genes that act as cell fate
determinants or signaling molecules, which in turn control pro-
liferation (Rezsohazy et al., 2015).
By contrast, our data on C. elegans vulval development indicate
that the hox gene lin-39 actively promotes cell cycle progression by
directly inducing the expression of core cell cycle regulators. LIN-
39 binds to a conserved sequence motif in the G1 cyclin gene cye-1
and possibly also in other genes encoding regulators of the G1 to
S-phase transition such as cdk-4 and cki-1. Interestingly, the LIN-
39 binding sites in these genes contain a non-canonical motif that
Fig. 5. Model for the regulation of VPC proliferation. Left cell: Before vulval induction, LIN-1 and LIN-31 repress lin-39 expression, while WNT signaling induces LIN-39
expression in all VPCs. LIN-39 maintains basal expression of the cell cycle regulators cye-1 and cdk-4 to prime the VPCs for later proliferation. In addition, LIN-31 promotes
cki-1 and represses cye-1 and cdk-4 expression, thereby inducing VPC quiescence. Middle cell: During vulval induction, EGFR/RAS/MAPK signaling in the 1° VPC results in the
inactivation of the LIN-1/LIN-31 complex via MAPK phosphorylation and hence a de-repression of lin-39. High LIN-39 levels induce cye-1, cdk-4 and lag-2 expression, while
cki-1 levels decline due to the inactivation of LIN-31. LAG-2 from the 1° VPC activates lateral NOTCH signaling in the adjacent 2° VPCs P5.p and P7.p. Right cell: NOTCH
signaling in the 2° VPCs P5.p and P7.p overcomes the LIN-31 repressor activity. Thus, the inactivation of LIN-1/LIN-31 by RAS/MAPK signaling in the 1° VPC and the activation
of NOTCH signaling in P5.p & P7.p lead to cell cycle progression upon vulval induction.
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appears to be derived from the canonical HOX/PBX binding site
(Mann and Affolter, 1998). The choice of HOX binding sites may be
determined by the type of co-factor present in the speciﬁc cellular
context. The two known HOX co-factors in C. elegans, CEH-20 PBX
and UNC-62 MEIS have so far not been implicated in controlling
VPC proliferation (Yang et al., 2005). Moreover, the existing ChIP-
seq data do not indicate a clear enrichment of UNC-62 at the HBSs
in the cye-1 and cdk-4 genes (Niu et al., 2011) (and own observa-
tion). On the other hand CEH-20 PBX negatively regulates eff-1
expression in the VPCs (Shemer and Podbilewicz, 2002) and may
therefore also act as a LIN-39 cofactor to control VPC proliferation.
By integrating our data into the existing framework of vulval
differentiation (Fig. 1A), we propose the following model ex-
plaining how lin-39 hox coordinates VPC cell fate speciﬁcation
with proliferation (Fig. 5). When the Pn.p cells are born at the end
of the L1 stage, a WNT signal produced by tail cells induces basal
levels of lin-39 expression to block cell fusion and specify the VPC
fate in the Pn.p cells of the mid-body region (P3.p through P8.p).
At the same time, LIN-39 maintains the expression of core cell
cycle regulators such as cdk-4 and cye-1, keeping the VPCs com-
petent to divide at a later stage (Fig. 5, left cell). Interestingly, LIN-
39 also activates the transcription of the cell cycle inhibitor cki-1.
This observation may initially appear contradictory to the role of
LIN-39 in promoting VPC proliferation. However, the relationship
between positive and negative cell cycle regulators is complex. The
mammalian CDK-4/Cyclin D complex sequesters the CKI-1 homo-
log p27/KIP1, which in turn stabilizes the CDK-4/Cyclin D complex
(Cheng et al., 1999). Thus, LIN-39 may activate the entire cell cycle
machinery rather than individual components to ensure a regu-
lated G1/S phase transition of the VPCs upon vulval induction.
In addition, the heterochronic protein LIN-28 and the LIN-31
transcription factor arrest the VPC cycle in the G1 phase by acti-
vating the expression of cki-1 and, at least in the case of LIN-31, by
repressing cdk-4 and cye-1 expression. As a result of these inter-
actions, the VPCs remain in the G1 phase until the end of the L2
stage, when LIN-28 levels are declining. At this stage, the 1° and 2°
fates are speciﬁed by the inductive EGFR and the lateral NOTCH
signals (Fig. 5, middle and right cells). EGFR/RAS/MAPK signaling
in the 1° lineage causes the phosphorylation and inactivation of
LIN-31 and LIN-1, which results in reduced cki-1 and increased lin-
39, cdk-4 and cye-1 levels (Maloof and Kenyon, 1998; Tan et al.,
1998). Activation of the NOTCH pathway in the 2° VPCs by the
lateral signal from the 1° VPC promotes cell cycle progression in-
dependently of LIN-39, LIN-1 and LIN-31. Since lateral NOTCH
signaling efﬁciently blocks EGFR/RAS/MAPK signaling in the 2°
lineage (Berset et al., 2001; Yoo et al., 2004), NOTCH probably
promotes cell cycle progression in a MAPK-independent fashion.
Whether NOTCH signaling directly up-regulates the expression of
cell cycle regulator genes in the 2° lineage or if NOTCH overcomes
the LIN-31 repressor activity through another mechanism remains
to be determined. However, since the forced expression of NICD
did not completely rescue the lin-39(lf) proliferation defect, LIN-39
and NOTCH signaling are likely to act in parallel.
In summary, we have found that the HOX protein LIN-39 reg-
ulates the VPC cycle at two levels. First, LIN-39 acts as a permissive
factor by maintaining the expression of the cell cycle machinery in
the VPCs, keeping them competent to proliferate. Second, LIN-39
triggers the lateral NOTCH signaling pathway in the adjacent 2°
VPCs, which overcomes the cell cycle inhibition by LIN-31 Fork-
head. LIN-39 is therefore a central node in a network that co-
ordinates VPC proliferation with fate speciﬁcation.
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